(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202412 | 202312 | % Var | 202412 | 202312 | % Var | 202403 | 202303 | % Var | |
| Sales | 42080.00 | 41157.50 | 2.24 | 124818.30 | 112706.20 | 10.75 | 146665.00 | 112588.30 | 30.27 |
| Other Income | 553.00 | 231.60 | 138.77 | 1270.00 | 765.00 | 66.01 | 1067.30 | 912.60 | 16.95 |
| PBIDT | 14663.50 | 12405.00 | 18.21 | 38516.10 | 28341.00 | 35.90 | 35657.90 | 11739.20 | 203.75 |
| Interest | 195.50 | 113.60 | 72.10 | 506.50 | 428.60 | 18.18 | 563.50 | 984.40 | -42.76 |
| PBDT | 13695.80 | 12291.40 | 11.43 | 37237.40 | 27912.40 | 33.41 | 35094.40 | 10754.80 | 226.31 |
| Depreciation | 1525.20 | 1451.80 | 5.06 | 4397.10 | 4347.10 | 1.15 | 7247.50 | 5483.40 | 32.17 |
| PBT | 12170.60 | 10839.60 | 12.28 | 32840.30 | 23565.30 | 39.36 | 27846.90 | 5271.40 | 428.26 |
| TAX | 2323.90 | 1675.20 | 38.72 | 6024.20 | 4145.20 | 45.33 | 4586.00 | 1019.30 | 349.92 |
| Deferred Tax | 66.60 | -170.90 | -138.97 | 155.50 | -4.70 | -3408.51 | -254.50 | 60.40 | -521.36 |
| PAT | 9846.70 | 9164.40 | 7.45 | 26816.10 | 19420.10 | 38.08 | 23260.90 | 4252.10 | 447.04 |
| Equity | 912.50 | 910.70 | 0.20 | 912.50 | 910.70 | 0.20 | 911.40 | 910.00 | 0.15 |
| PBIDTM(%) | 34.85 | 30.14 | 15.61 | 30.86 | 25.15 | 22.71 | 24.31 | 10.43 | 133.18 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: